UnknownNot applicableNCT00563498
Effects on Glutamine on the Outcome of Allogeneic Bone Marrow Transplant Recipients
Studying Hepatic veno-occlusive disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Hospital Authority, Hong Kong
- Principal Investigator
- Albert Lie, DrDepartment of Medicine/Division of Haematology, Queen Mary Hospital/ The University of Hong Kong
- Intervention
- Glutamine(drug)
- Enrollment
- 40 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2004 – 2006
Study locations (1)
- Queen Mary Hospital, Hong Kong, China
Collaborators
The University of Hong Kong · Fresienius Kabi HK Ltd
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00563498 on ClinicalTrials.govOther trials for Hepatic veno-occlusive disease
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT05987124Defibrotide Dose-escalation for SOS Post-HSCTNew York Medical College
- RECRUITINGNCT06715046Cell Free DNA Profiling As a Tool to Monitor Clinically-Relevant Events in Allogeneic Hematopoietic Stem Cell TransplantationUniversity of Turin, Italy
- RECRUITINGNCT05090345A Prospective Registry of Pediatric Cellular Therapy Patients at Risk for Endothelial Dysfunction, Sinusoidal Obstruction Syndrome and/or Multi-Organ Dysfunction Syndrome (MODS).Duke University
- ACTIVE NOT RECRUITINGNANCT03865589Using Ultrasound Elastography to Predict Development of Hepatic Sinusoidal Obstruction SyndromeChildren's Mercy Hospital Kansas City